Clinical Trials Browser

Phase 2 × Completed × Bone-Metastatic, Castration-Resistant Prostate Cancer × Clear all

NCT01074138 2023-02-02

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Phase 2 Completed

Bone-Metastatic, Castration-Resistant Prostate Cancer